Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 733

Sort by

Sort Order Select

Journal Articles

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Andreas Tiede, Ulrich J. Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K. Krauss, Frank Donnerstag, Karin Weißenborn, Günter Höglinger, Benjamin Maasoumy, Heiner Wedemeyer, Arnold Ganser

Blood (2021) 138 (4): 350–353.

https://doi.org/10.1182/blood.2021011958

Published: 2021

Includes: Supplemental data

Journal Articles

Diversity, localization, and (patho)physiology of mature lymphocyte populations in the bone marrow

Christian M. Schürch, Chiara Caraccio, Martijn A. Nolte

Blood (2021) 137 (22): 3015–3026.

https://doi.org/10.1182/blood.2020007592

Published: 2021

Includes: Supplemental data

Journal Articles

Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition

Peter A. A. Norris, Gurleen Kaur, Ramsha Khan, Guangheng Zhu, Heyu Ni, Alan H. Lazarus

Blood (2021) 137 (15): 2114–2124.

https://doi.org/10.1182/blood.2020009497

Published: 2021

Includes: Supplemental data

Journal Articles

Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP

Ramsha Khan, Melissa Menard, Chao-Ching Jen, Xi Chen, Peter A. A. Norris, Alan H. Lazarus

Blood (2020) 135 (26): 2420–2424.

https://doi.org/10.1182/blood.2019003646

Published: 2020

Includes: Supplemental data

Journal Articles

The never-ending enigma of immune thrombocytopenia

Karin M. Hoffmeister

Blood (2020) 135 (25): 2207–2209.

https://doi.org/10.1182/blood.2020005555

Published: 2020

Journal Articles

Mechanisms of anti-GPIbα antibody–induced thrombocytopenia in mice

Yosuke Morodomi, Sachiko Kanaji, Eric Won, Zaverio M. Ruggeri, Taisuke Kanaji

Blood (2020) 135 (25): 2292–2301.

https://doi.org/10.1182/blood.2019003770

Published: 2020

Includes: Supplemental data

Journal Articles

Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment

Oriana Miltiadous, Ming Hou, James B. Bussel

Blood (2020) 135 (7): 472–490.

https://doi.org/10.1182/blood.2019003599

Published: 2020

Journal Articles

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

Carlo Visco, Francesco Rodeghiero, Alessandra Romano, Federica Valeri, Michele Merli, Giulia Quaresimini, Stefano Volpetti, Roberto M. Santi, Giuseppe Carli, Elisa Lucchini, Francesco Passamonti, Alessandro Rambaldi, Giovanna Motta, Alessandra Borchiellini, Emanuele S. G. d’Amore, Marco Ruggeri

Blood (2019) 134 (20): 1708–1711.

https://doi.org/10.1182/blood.2019001617

Published: 2019

Includes: Supplemental data

Journal Articles

Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)

Leona Raskova Kafkova, MSc, PhD, Diana Brokesova, MSc, Zbynek Novak, MD, Milan Raska, Prof. MD MSc, PhD, Dagmar Pospisilova, Prof MD PhD, Jana Volejnikova, MD

Blood (2019) 134 (Supplement_1): 221.

https://doi.org/10.1182/blood-2019-122095

Published: 2019

Journal Articles

An Adapting Bone Marrow Niche Creates a Nurturing Environment for Hematopoiesis during Immune Thrombocytopenia Progression

Oliver Herd, BSc, Maria Abril Arredondo Garcia, BSc, James Hewitson, PhD, Karen Hogg, PhD, Saleni Pravin Kumar, BSc, Katiuska Pulgar Prieto, BSc, Andrew Stone, BSc, Paul Genever, PhD, Ian Hitchcock, PhD

Blood (2019) 134 (Supplement_1): 222.

https://doi.org/10.1182/blood-2019-129795

Published: 2019

Journal Articles

Immunoglobulin Levels As Predictors of the Development of Chronic Disease in Pediatric Immune Thrombocytopenia

Amanda Bell Grimes, MD, Taylor Olmsted Kim, MD, Jenny M. Despotovic, DO, MS, Susan Kirk, PA-C

Blood (2019) 134 (Supplement_1): 388.

https://doi.org/10.1182/blood-2019-132285

Published: 2019

Journal Articles

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Philip Griffiths, Laura Grant, Nicola Bonner, MSc, Denise D'Alessio, MBA, Quentin A. Hill, Drew Provan, MD, Waleed Ghanima, MD PhD, Nichola Cooper, MD MRCP, Ricardo Viana, PhD

Blood (2019) 134 (Supplement_1): 386.

https://doi.org/10.1182/blood-2019-125766

Published: 2019

Journal Articles

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

Lauryn S. Walker, Taylor Olmsted Kim, MD, Amanda Bell Grimes, MD, Susan Kirk, PA-C, Audrey S. Cohen, Abinaya Arulselvan, Scott E. Wenderfer, MD, Michele P. Lambert, MD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 387.

https://doi.org/10.1182/blood-2019-130418

Published: 2019

Journal Articles

ATRA Could Correct the Defective S1P-Mediated Cytoskeletal Reorganization in Proplatelet Formation of ITP

Qiu-Sha Huang, Jing Xue, Chen-Cong Wang, Ya-Zhen Qin, Lan-Ping Xu, Kaiyan Liu, Xiao-Jun Huang, MD, Xiao-Hui Zhang

Blood (2019) 134 (Supplement_1): 218.

https://doi.org/10.1182/blood-2019-126384

Published: 2019

Journal Articles

Cutaneous Hemorrhage Types As Supportive Factors for Predicting Chronic Immune Thrombocytopenia in Children

Nehama Sharon

Blood (2019) 134 (Supplement_1): 4906.

https://doi.org/10.1182/blood-2019-121380

Published: 2019

Journal Articles

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD

Blood (2019) 134 (Supplement_1): 4912.

https://doi.org/10.1182/blood-2019-124740

Published: 2019

Journal Articles

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review

Alejandro Garcia-Horton, MDFRCPC, Yashoda Valliere, Alejandro Lazo-Langner, MD MSc

Blood (2019) 134 (Supplement_1): 5425.

https://doi.org/10.1182/blood-2019-126806

Published: 2019

Journal Articles

Eltrombopag Following Chemotherapy and G-CSF+/- Plerixafor for Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Lymphoma and Myeloma Patients

Krishna Joshi, MD, Appalanaidu Sasapu, MD, Muthu Veeraputhiran, MD, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Michele H Cottler-Fox, MD

Blood (2019) 134 (Supplement_1): 5638.

https://doi.org/10.1182/blood-2019-124629

Published: 2019

Journal Articles

The Burden of Disease and IMPACT of Immune Thrombocytopenia (ITP) on Patients: Results from an ITP Survey

James B. Bussel, MD, Alexandra Kruse, Caroline Kruse, Jody Shy, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Keith R McCrae, MD

Blood (2019) 134 (Supplement_1): 1076.

https://doi.org/10.1182/blood-2019-131351

Published: 2019

Journal Articles

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Mark Rasmussen, Daniel W. Bougie, PhD, Gregory H. Denomme, Richard H. Aster, MD

Blood (2019) 134 (Supplement_1): 1078.

https://doi.org/10.1182/blood-2019-130966

Published: 2019

NARROW

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Diversity, localization, and (patho)physiology of mature lymphocyte populations in the bone marrow

Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition

Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP

The never-ending enigma of immune thrombocytopenia

Mechanisms of anti-GPIbα antibody–induced thrombocytopenia in mice

Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

Platelet Desialylation As a Predictive Marker in Childhood Immune Thrombocytopenia (ITP)

An Adapting Bone Marrow Niche Creates a Nurturing Environment for Hematopoiesis during Immune Thrombocytopenia Progression

Immunoglobulin Levels As Predictors of the Development of Chronic Disease in Pediatric Immune Thrombocytopenia

The Psychometric Properties of the ITP Life Quality Index Assessed in a Large Multinational "Real-World" Cohort of Immune Thrombocytopaenia Patients

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

ATRA Could Correct the Defective S1P-Mediated Cytoskeletal Reorganization in Proplatelet Formation of ITP

Cutaneous Hemorrhage Types As Supportive Factors for Predicting Chronic Immune Thrombocytopenia in Children

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review

Eltrombopag Following Chemotherapy and G-CSF+/- Plerixafor for Mobilization and Collection of Hematopoietic Progenitor Cells (HPC) in Lymphoma and Myeloma Patients

The Burden of Disease and IMPACT of Immune Thrombocytopenia (ITP) on Patients: Results from an ITP Survey

Serologic Characterization of Antibodies in Patients Experiencing Piperacillin-Induced Immune Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only